| 736388 |
FRONTIERS IN GENETICS |
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa |
2021-09-01 |
10.3389/fgene.2021.705019 |
De Rosa Laura, Enzo Elena, Zardi Giulia, Bodemer Christine, Magnoni Cristina, Schneider Holm, De Luca Michele |
| 736387 |
FRONTIERS IN GENETICS |
Impact of Genomic Prediction Model, Selection Intensity, and Breeding Strategy on the Long-Term Genetic Gain and Genetic Erosion in Soybean Breeding |
2021-09-01 |
10.3389/fgene.2021.637133 |
Silva Éder David Borges da, Xavier Alencar, Faria Marcos Ventura |
| 736386 |
FRONTIERS IN GENETICS |
Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis |
2021-09-01 |
10.3389/fgene.2021.654517 |
Zhang Jingyuan, Liu Xinkui, Zhou Wei, Lu Shan, Wu Chao, Wu Zhishan, Liu Runping, Li Xiaojiaoyang, Wu Jiarui, Liu Yingying, Guo Siyu, Jia Shanshan, Zhang Xiaomeng, Wang Miaomiao |
| 736385 |
FRONTIERS IN ONCOLOGY |
Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells |
2021-09-01 |
10.3389/fonc.2021.707366 |
Merlos Rodrigo Miguel Angel, Casar Berta, Michalkova Hana, Jimenez Jimenez Ana Maria, Heger Zbynek, Adam Vojtech |
| 736384 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection |
2021-09-01 |
10.3389/fonc.2021.711206 |
Shen Yu-Jia, Qian Li-Qiang, Ding Zheng-Ping, Luo Qing-Quan, Zhao Heng, Xia Wu-Yan, Fu Yuan-Yuan, Feng Wen, Zhang Qin, Yu Wen, Cai Xu-Wei, Fu Xiao-Long |
| 736383 |
FRONTIERS IN ONCOLOGY |
Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma |
2021-09-01 |
10.3389/fonc.2021.698497 |
Shen Yutao, Li Mingxuan, Xiong Yujia, Gui Songbai, Bai Jiwei, Zhang Yazhuo, Li Chuzhong |
| 736382 |
FRONTIERS IN ONCOLOGY |
The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application |
2021-09-01 |
10.3389/fonc.2021.686369 |
Aili Yirizhati, Maimaitiming Nuersimanguli, Mahemuti Yusufu, Qin Hu, Wang Yongxin, Wang Zengliang |
| 736381 |
FRONTIERS IN ONCOLOGY |
Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference |
2021-09-01 |
10.3389/fonc.2021.726034 |
Zhang Meng, Wang Dan, Su Lan, Ma Jingjiao, Wang Sizhen, Cui Meng, Hong Shunming, Guan Bing, Ma Xiaodong |
| 736380 |
FRONTIERS IN ONCOLOGY |
Rictor Activates Cav 1 Through the Akt Signaling Pathway to Inhibit the Apoptosis of Gastric Cancer Cells |
2021-09-01 |
10.3389/fonc.2021.641453 |
Cao Rui-zhen, Min Li, Liu Si, Tian Ru-yue, Jiang Hai-yan, Liu Juan, Shao Lin-lin, Cheng Rui, Zhu Sheng-tao, Guo Shui-long, Li Peng |
| 736379 |
FRONTIERS IN ONCOLOGY |
The 100 Most Cited Papers in Radiotherapy or Chemoradiotherapy for Cervical Cancer: 1990–2020 |
2021-09-01 |
10.3389/fonc.2021.642018 |
Wang Weiping, Liu Xiaoliang, Wang Dunhuang, Ren Kang, Zhou Yuncan, Zhou Ziqi, Qiu Jie, Zhang Fuquan, Hu Ke |
